This company has been marked as potentially delisted and may not be actively trading. Capstar Special Purpose Acquisition (CPSR) Institutional Ownership Add Compare Share Share Ownership Stock AnalysisCompetitorsOwnershipTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Capstar Special Purpose Acquisition (NYSE:CPSR)CurrentInstitutional OwnershipPercentage64.87%Number ofInstitutional Buyers(last 12 months)3TotalInstitutional Inflows(last 12 months)$608.62KNumber ofInstitutional Sellers(last 12 months)0 Get CPSR Insider Trade Alerts Want to know when executives and insiders are buying or selling Capstar Special Purpose Acquisition stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data CPSR Institutional Buying and Selling by Quarter Capstar Special Purpose Acquisition Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/4/2025 Creative Financial Designs Inc. ADV1,437$35K0.0%N/A0.004% 7/11/2025 Farther Finance Advisors LLC13,816$336K0.0%N/A0.040% 7/10/2025 Worth Asset Management LLC9,824$239K0.1%N/A0.028% 2/17/2022 Omni Event Management Ltd1,035,951$10.32M0.6%N/A3.003% 2/15/2022Karpus Management Inc.81,958$816K0.0%-7.7%0.238% 2/15/2022Kohlberg Kravis Roberts & Co. L.P.162,875$1.62M0.0%-17.8%0.472% 2/10/2022Iron Park Capital Partners LP650,000$6.47M5.2%N/A1.884% 2/10/2022Qube Research & Technologies Ltd709,924$7.07M0.1%N/A2.058% 2/10/2022Picton Mahoney Asset Management400,000$4M0.1%-11.1%1.159% 2/8/2022 RPO LLC1,007,386$10.03M3.1%N/A2.920% Get the Latest News and Ratings for CPSR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Capstar Special Purpose Acquisition and its competitors with MarketBeat's FREE daily newsletter. 2/1/2022Qube Research & Technologies Ltd709,924$7.07M0.1%N/A2.058% 1/19/2022 Tuttle Capital Management LLC33,860$337K0.5%-26.9%0.098% 1/14/2022Clear Street LLC82,100$818K0.0%N/A0.238% 11/16/2021Schonfeld Strategic Advisors LLC154,833$1.54M0.0%+344.2%0.449% 11/16/2021Verition Fund Management LLC16,242$161K0.0%-85.1%0.047% 11/16/2021Citadel Advisors LLC1,636,394$16.23M0.0%+53.5%4.743% 11/15/2021Ancora Advisors LLC4,559$45K0.0%N/A0.013% 11/15/2021Berkley W R Corp376,752$3.74M0.3%+14.2%1.092% 11/15/2021Westchester Capital Management LLC564,081$5.60M0.2%N/A1.635% 11/15/2021CSS LLC IL21,843$217K0.0%N/A0.063% 11/15/2021OMERS ADMINISTRATION Corp10,000$99K0.0%N/A0.029% 11/12/2021Falcon Edge Capital LP222,664$2.21M0.2%N/A0.645% 11/12/2021Periscope Capital Inc.1,450,761$14.39M0.4%-7.5%4.205% 11/12/2021Weiss Asset Management LP536,285$5.32M0.1%N/A1.554% 11/12/2021 Wolverine Asset Management LLC130,778$1.30M0.0%-7.0%0.379% 11/12/2021Hsbc Holdings PLC230,631$2.29M0.0%+67.2%0.668% 11/12/2021Cohanzick Management LLC32,201$319K0.1%+84.2%0.093% 11/4/2021 Aequim Alternative Investments LP50,000$44K0.0%N/A0.145% 10/22/2021 Tuttle Capital Management LLC46,308$459K0.2%-21.7%0.134% 10/19/2021 Seelaus Asset Management LLC42,170$418K0.2%-7.9%0.122% 8/17/2021Kohlberg Kravis Roberts & Co. L.P.27,176$266K0.0%N/A0.079% 8/17/2021Citadel Advisors LLC1,066,113$10.44M0.0%-0.8%3.090% 8/16/2021Bank of America Corp DE155,337$1.52M0.0%+9.5%0.450% 8/16/2021Berkley W R Corp329,950$3.23M0.3%+56.3%0.956% 8/16/2021Schonfeld Strategic Advisors LLC34,860$341K0.0%+40.2%0.101% 8/16/2021Cohanzick Management LLC17,480$171K0.1%N/A0.051% 8/13/2021EJF Capital LLC20,000$196K0.0%N/A0.058% 8/13/2021Basso Capital Management L.P.10,013$98K0.0%N/A0.029% 8/12/2021 Penserra Capital Management LLC9,224$90K0.0%-15.7%0.027% 8/11/2021Susquehanna International Group LLP26,272$257K0.0%-9.9%0.076% The Coin That Could Define Trump’s Crypto Presidency (Ad)When Trump returned to office, one of his first moves was to tap PayPal’s former COO, David Sacks, as a top advisor on crypto and AI. That alone signaled a shift. But insiders close to D.C. aren’t just talking crypto policy—they’re quietly buying something most retail investors have missed. While the crowd chases Bitcoin to $150,000, Weiss Ratings expert Juan Villaverde believes a different coin—already backed by giants like Google, Visa, and PayPal—could soon become crypto’s “Third Giant.”Discover the coin that could define Trump’s crypto presidency.7/31/2021 Tuttle Tactical Management59,145$579K0.3%-25.1%0.171% (Data available from 1/1/2016 forward) CPSR Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CPSR shares? During the previous two years, the following institutional investors and hedge funds held shares of Capstar Special Purpose Acquisition shares: Farther Finance Advisors LLC ($336K), and Worth Asset Management LLC ($239K), Creative Financial Designs Inc. ADV ($35K).Learn more on Capstar Special Purpose Acquisition's institutional investors. What percentage of Capstar Special Purpose Acquisition's stock is owned by institutional investors? 64.87% of Capstar Special Purpose Acquisition's stock is owned by institutional investors. Learn more on CPSR's institutional investor holdings. Which institutional investors have been buying Capstar Special Purpose Acquisition's stock? The following institutional investors have purchased Capstar Special Purpose Acquisition's stock in the last 24 months: Farther Finance Advisors LLC ($13.82K), Worth Asset Management LLC ($9.82K), and Creative Financial Designs Inc. ADV ($1.44K). How much institutional buying is happening at Capstar Special Purpose Acquisition? Institutional investors have bought a total of 25,077 shares in the last 24 months. This purchase volume represents approximately $608.62K in transactions. Related Companies MorphoSys Institutional Ownership Calliditas Therapeutics AB (publ) Institutional Ownership Zymeworks Institutional Ownership MBX Biosciences Institutional Ownership Aerovate Therapeutics Institutional Ownership Cybin Institutional Ownership BioAge Labs Institutional Ownership OS Therapies Institutional Ownership Eliem Therapeutics Institutional Ownership Actinium Pharmaceuticals Institutional Ownership This page (NYSE:CPSR) was last updated on 8/13/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCritical AI announcement set to ignite AI 2.0I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredNew Federal Land Rush About to Start?A $100 Trillion Wealth Shift Is Already Underway Lithium. Oil. Gold. Trillions in U.S. resources are being ...Stansberry Research | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Capstar Special Purpose Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Capstar Special Purpose Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access